Polymeric nanoparticles conjugate a novel heptapeptide as an epidermal growth factor receptor-active targeting ligand for doxorubicin
Chia Wen Liu,1,2 Wen Jen Lin11Graduate Institute of Pharmaceutical Sciences, College of Medicine, National Taiwan University, Taipei; 2Drug Delivery Department, Biomedical Engineering Research Laboratories, Industrial Technology Research Institute, Hsinchu, TaiwanBackground: This study was performed...
Saved in:
Main Authors: | Liu CW, Lin WJ |
---|---|
Format: | article |
Language: | EN |
Published: |
Dove Medical Press
2012
|
Subjects: | |
Online Access: | https://doaj.org/article/14e1f955835a4a8c9d24cce75b5b1f73 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A novel small peptide as an epidermal growth factor receptor targeting ligand for nanodelivery in vitro
by: Han CY, et al.
Published: (2013) -
Aptamer-Conjugated Gold Nanoparticles Targeting Epidermal Growth Factor Receptor Variant III for the Treatment of Glioblastoma
by: Peng L, et al.
Published: (2020) -
Targeted delivery of polyamidoamine-paclitaxel conjugate functionalized with anti-human epidermal growth factor receptor 2 trastuzumab
by: Ma P, et al.
Published: (2015) -
Superparamagnetic iron oxide nanoparticles conjugated with epidermal growth factor (SPION–EGF) for targeting brain tumors
by: Shevtsov MA, et al.
Published: (2014) -
Aptamer-conjugated PEGylated quantum dots targeting epidermal growth factor receptor variant III for fluorescence imaging of glioma
by: Tang J, et al.
Published: (2017)